HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Nunn, A. D. Articles by Conley, R. A. Search for Related Content PubMed PubMed Citation Articles by Nunn, A. D. Articles by Conley, R. A.

A Structure-Distribution-Relationship Approach Leading to the Development of Tc-99m Mebrofenin: An Improved Cholescintigraphic Agent

Squibb Institute for Medical Research, New Brunswick, New Jersey

Correspondence: For reprints contact: Dr. A. D. Nunn, Squibb Institute for Medical Research, P.O. Box 191, New Brunswick, NJ 08901.

ABSTRACT

Thirty-three HIDA (hepatobiliary IDA) derivatives were tested and correlations drawn between physicochemical parameters, structural effects, and In vivo characteristics. Capacity factors of the ligands on reverse-phase HPLC were used as a measure of lipophilicity and to predict protein binding and in vivo distribution of the complexes. Fragmentary values were used to derive theoretical lipophilicities, which showed that ortho substituents have reduced lipophilic activity, probably because of self-shielding. Ortho substitution was found to affect hepatocellular transit times. Various combinations of substituents with the desired overall lipophilicity were tested. The best compound, Tc-3-bromo-2,4,6-trimethyl HIDA, possessed high hepatic specificity, and rapid hepatocellular transit; It was also resistant to competition for hepatobiliary excretion from bilirubin.